Computer Research and Modeling
RUS  ENG    JOURNALS   PEOPLE   ORGANISATIONS   CONFERENCES   SEMINARS   VIDEO LIBRARY   PACKAGE AMSBIB  
General information
Latest issue
Archive

Search papers
Search references

RSS
Latest issue
Current issues
Archive issues
What is RSS



Computer Research and Modeling:
Year:
Volume:
Issue:
Page:
Find






Personal entry:
Login:
Password:
Save password
Enter
Forgotten password?
Register


Computer Research and Modeling, 2022, Volume 14, Issue 3, Pages 647–660
DOI: https://doi.org/10.20537/2076-7633-2022-14-3-647-660
(Mi crm988)
 

ANALYSIS AND MODELING OF COMPLEX LIVING SYSTEMS

Mathematical modeling the kinetics and calculation of dosimetric characteristics of osteotropic radiopharmaceutical drugs

A. V. Matveev

Dostoevsky Omsk State University, 55a Mira av., Omsk, 644077, Russia
References:
Abstract: In Russian medicine two radiopharmaceuticals are currently used for radionuclide therapy of bone metastases: $^{89}$Sr-chloride and $^{153}$Sm-oxabifor. The first one has many side effects, so its use is limited. The second one is available only in clinics, its transportation to which does not take much time. Currently, the third radiopharmaceutical $^{188}$Re-solerene is undergoing clinical trials. Due to the generator method of obtaining $^{188}$Re, this radiopharmaceutical should become available for use in many regions of our country. Therefore, there is a need for a comparative analysis of the characteristics of these radiopharmaceuticals, including on the basis of mathematical modeling.
The article discusses the features of mathematical modeling the kinetics of osteotropic radiopharmaceutical drugs in the human body with bone metastases. Based on the four-compartment model, a complex of modeling and calculation of pharmacokinetic and dosimetric characteristics of radiopharmaceuticals for radionuclidetherapy of bone metastases was developed and tested. Using clinical data, the transport constants of the model were identified and the individual characteristics of Russian radiopharmaceuticals labeled $^{89}$Sr, $^{153}$Sm and $^{188}$Re were calculated (effective half-lives, maximum activity in the compartments and the times of their achievement, absorbed doses to bone tissue and metastases, endosteal bone layer, red bone marrow, blood, kidneys and bladder). The time activity dependencies for all compartments of the model are obtained and analyzed. A comparative analysis of the pharmacokinetics and dosimetry of three radiopharmaceuticals ($^{89}$Sr-chloride, $^{153}$Sm-oxabiphore, $^{188}$Re-solerene) was carried out.
From a comparative analysis of the pharmacokinetic and dosimetric characteristics of these radiopharmaceutical drugs, it follows that the best of them for wide spread use in many regions of our country should be $^{188}$Re-solerene, taking into account the generator method of obtaining $^{188}$Re in a hospital.
Keywords: mathematical modeling, nuclear medicine, dosimetry, kinetics, radiopharmaceutical, compartment model.
Received: 18.01.2022
Revised: 27.02.2022
Accepted: 02.03.2022
Document Type: Article
UDC: 577.34
Language: Russian
Citation: A. V. Matveev, “Mathematical modeling the kinetics and calculation of dosimetric characteristics of osteotropic radiopharmaceutical drugs”, Computer Research and Modeling, 14:3 (2022), 647–660
Citation in format AMSBIB
\Bibitem{Mat22}
\by A.~V.~Matveev
\paper Mathematical modeling the kinetics and calculation of dosimetric characteristics of osteotropic radiopharmaceutical drugs
\jour Computer Research and Modeling
\yr 2022
\vol 14
\issue 3
\pages 647--660
\mathnet{http://mi.mathnet.ru/crm988}
\crossref{https://doi.org/10.20537/2076-7633-2022-14-3-647-660}
Linking options:
  • https://www.mathnet.ru/eng/crm988
  • https://www.mathnet.ru/eng/crm/v14/i3/p647
  • Citing articles in Google Scholar: Russian citations, English citations
    Related articles in Google Scholar: Russian articles, English articles
    Computer Research and Modeling
    Statistics & downloads:
    Abstract page:76
    Full-text PDF :34
    References:20
     
      Contact us:
     Terms of Use  Registration to the website  Logotypes © Steklov Mathematical Institute RAS, 2024